Delayed cutaneous hypersensitivity in patients with prostatic adenocarcinoma.

[1]  W. Catalona,et al.  Abnormalities of cell-mediated immunocompetence in genitourinary cancer. , 1974, The Journal of urology.

[2]  R. Gittes,et al.  Immunologic competence in patients with urologic cancer. , 1974, The Journal of urology.

[3]  C. Olsson,et al.  Immunologic reduction of bladder cancer recurrence rate. , 1974, Transactions of the American Association of Genito-Urinary Surgeons.

[4]  W. Catalona,et al.  Correlation among host immunocompetence and tumor stage, tumor grade and vascular permeation in transitional carcinoma. , 1973, Journal of Urology.

[5]  D. Morton.  Immunotherapy of cancer. Present Status and Future Potential , 1972, Cancer.

[6]  W. Catalona,et al.  Quantitative dinitrochlorobenzene contact sensitization in a normal population. , 1972, Clinical and experimental immunology.

[7]  H. Sjögren,et al.  Demonstration of cell‐mediated immunity to human neoplasms of various histological types , 1971, International journal of cancer.

[8]  W. Frable,et al.  Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation , 1970 .

[9]  T. Starzl,et al.  Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). , 1970, Annals of surgery.

[10]  D. Morton,et al.  Impaired immunologic reactivity and recurrence following cancer surgery , 1970, Cancer.

[11]  J. Alexander,et al.  Immunobiology for Surgeons , 1970 .